Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 213,064 |
|
|||||
| News | - | ||||||
| Day High | 88.43 | Low High |
|||||
| Day Low | 87.29 | ||||||
| Etf Name | Etf Symbol | Market | Stock Type |
|---|---|---|---|
| VanEck Pharmaceuticals ETF | PPH | NASDAQ | Exchange Traded Fund |
| Price Change | Price Change % | Etf Price | Last Trade
|
|
|---|---|---|---|---|
| 0.40 | 0.46% | 87.96 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 87.55 | 87.29 | 88.43 | 87.96 | 87.56 |
| Trades | Etfs Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,247 | 213,064 | 87.83 | 18,714,380 | - | 74.05 - 91.16 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:57:12 | 2 | 87.50 | USD |
VanEck Pharmaceuticals ETF Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 474.09M | 5.39M | - | 10.39M | 92.32M | 17.13 | 5.14 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News VanEck Pharmaceuticals ETF
| Date | Time | Source | Heading |
|---|---|---|---|
| 9/14/2023 | 09:25 | GlobeNewswire Inc. | Technology Leader Pushpay Announces Executive Leadership.. |
| 7/25/2023 | 14:36 | GlobeNewswire Inc. | Pushpay Expands Giving Options, Announces Free.. |
| 6/29/2023 | 13:51 | GlobeNewswire Inc. | Pushpay Launches Church Tech Check, a New Assessment Tool to.. |
| 5/16/2023 | 08:00 | GlobeNewswire Inc. | Pushpay Announces Everygift™, Suite of Product Features that.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
PPH Historical
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 86.92 | 88.43 | 86.00 | 87.00 | 381,669 | 1.04 | 1.20% |
| 1 Month | 88.79 | 89.41 | 84.64 | 86.77 | 166,778 | -0.83 | -0.93% |
| 3 Months | 87.66 | 91.16 | 84.64 | 88.34 | 149,201 | 0.30 | 0.34% |
| 6 Months | 75.31 | 91.16 | 75.30 | 85.11 | 125,529 | 12.65 | 16.80% |
| 1 Year | 78.79 | 91.16 | 74.05 | 82.22 | 125,762 | 9.17 | 11.64% |
| 3 Years | 69.76 | 91.16 | 66.59 | 77.88 | 117,991 | 18.20 | 26.09% |
| 5 Years | 58.18 | 91.16 | 46.90 | 73.81 | 96,786 | 29.78 | 51.19% |
| The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the funds benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified. |
